Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Waitlist survival at 90 days improved from 86.5% before ...
Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...
Prognostic scores are valuable tools for predicting survival in patients with chronic liver disease. Recently, the albumin-bilirubin (ALBI) score has emerged as a potential prognostic indicator in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results